WNT5A and prostate carcinoma: While Wnt5a has been described as a tumor promoter in melanoma, gastric, pancreatic, and prostate cancers, it was suggested to be a tumor suppressor in HCC, neuroblastoma, leukemia, colon, and thyroid cancers [32].